"T-Lymphocytes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.
Descriptor ID |
D013601
|
MeSH Number(s) |
A11.118.637.555.567.569 A15.145.229.637.555.567.569 A15.382.490.555.567.569
|
Concept/Terms |
T-Lymphocytes- T-Lymphocytes
- T Lymphocytes
- T-Lymphocyte
- T-Cells
- T Cells
- T-Cell
- Thymus-Dependent Lymphocytes
- Lymphocyte, Thymus-Dependent
- Lymphocytes, Thymus-Dependent
- Thymus Dependent Lymphocytes
- Thymus-Dependent Lymphocyte
|
Below are MeSH descriptors whose meaning is more general than "T-Lymphocytes".
Below are MeSH descriptors whose meaning is more specific than "T-Lymphocytes".
This graph shows the total number of publications written about "T-Lymphocytes" by people in this website by year, and whether "T-Lymphocytes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 12 | 8 | 20 |
1995 | 14 | 9 | 23 |
1996 | 8 | 6 | 14 |
1997 | 13 | 7 | 20 |
1998 | 15 | 6 | 21 |
1999 | 18 | 10 | 28 |
2000 | 4 | 9 | 13 |
2001 | 19 | 7 | 26 |
2002 | 16 | 17 | 33 |
2003 | 20 | 12 | 32 |
2004 | 17 | 12 | 29 |
2005 | 10 | 9 | 19 |
2006 | 17 | 6 | 23 |
2007 | 16 | 13 | 29 |
2008 | 10 | 7 | 17 |
2009 | 17 | 16 | 33 |
2010 | 10 | 12 | 22 |
2011 | 18 | 9 | 27 |
2012 | 11 | 15 | 26 |
2013 | 20 | 12 | 32 |
2014 | 17 | 18 | 35 |
2015 | 19 | 17 | 36 |
2016 | 13 | 17 | 30 |
2017 | 11 | 10 | 21 |
2018 | 16 | 12 | 28 |
2019 | 14 | 7 | 21 |
2020 | 16 | 7 | 23 |
2021 | 7 | 13 | 20 |
2022 | 8 | 13 | 21 |
2023 | 5 | 12 | 17 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "T-Lymphocytes" by people in Profiles.
-
Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy. J Immunol. 2024 01 15; 212(2):188-198.
-
Base-editing mutagenesis maps alleles to tune human T cell functions. Nature. 2024 Jan; 625(7996):805-812.
-
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial. Nat Med. 2023 10; 29(10):2570-2576.
-
CRISPR screens decode cancer cell pathways that trigger ?d T cell detection. Nature. 2023 Sep; 621(7977):188-195.
-
Mechanoregulatory Cholesterol Oxidase-Functionalized Nanoscale Metal-Organic Framework Stimulates Pyroptosis and Reinvigorates T Cells. Small. 2023 Dec; 19(52):e2305440.
-
Biological Time Travel: Tracking the Journey of Alloreactive T Cells Through Longitudinal Biobanking. Transplantation. 2023 09 01; 107(9):1862-1864.
-
Developing Targeted Therapies for T Cell Acute Lymphoblastic Leukemia/Lymphoma. Curr Hematol Malig Rep. 2023 Dec; 18(6):217-225.
-
Immunosuppressive effects of new thiophene-based KV1.3 inhibitors. Eur J Med Chem. 2023 Nov 05; 259:115561.
-
A randomised, double-blind, placebo-controlled study of the LAG-3-depleting monoclonal antibody GSK2831781 in patients with active ulcerative colitis. Aliment Pharmacol Ther. 2023 08; 58(3):283-296.
-
Infection rates are high across the multiple myeloma continuum, not just with bispecific antibodies. Eur J Cancer. 2023 08; 189:112926.